Clarus Lifesciences II, L.P., 10% Owner at ACHILLION PHARMACEUTICALS INC (ACHN), sold 284,000 shares at $3.70 ($1.0M) on 2009-12-23, disclosed to the SEC on 2009-12-23.
Scheduled sale ($1.0M) by 10% Owner under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $3.54 | 19,100 | $68K | 6.5% |
| 2 | $3.70 | 264,900 | $980K | 93.5% |
| Total | $3.69 avg | 284,000 | $1.0M | 100% |
| Filing → |
| ACHN | SELL | 2009-12-18 | $731K | — | Filing → |